Additionally, research confirmed that BL‐918 could significantly alleviate the progression of PD in a 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced PD mouse model in a PINK1‐dependent manner, providing important experimental evidence for its potential as a therapeutic drug for PD [162]. Here, PINK1 is linked to Parkinson disease.